A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: A Southwest Oncology Group study 9617

Thomas R. Chauncey, Cathryn Rankin, Jeanne E. Anderson, I. Ming Chen, Kenneth J. Kopecky, John E. Godwin, Matt E. Kalaycio, Dennis F. Moore, Muhammad S. Shurafa, Stephen H. Petersdorf, Eric H. Kraut, Catherine P. Leith, David R. Head, Frederick W. Luthardt, Cheryl L. Willman, Frederick R. Appelbaum

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: A Southwest Oncology Group study 9617'. Together they form a unique fingerprint.

Medicine & Life Sciences